Telescope Innovations's EBIT per Share for the
three
months ended in May. 2026 was $-0.01.
Its EBIT per Share for the trailing twelve months (TTM) ended in May. 2026 was $-0.04.
During the past 3 years, the average EBIT per Share Growth Rate was 40.60% per year.
During the past 5 years, the average EBIT per Share Growth Rate was -12.10% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Telescope Innovations's EBIT per Share or its related term are showing as below:
TELIF'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -67.1 Med: 39.1 Max: 40.6
Current: 40.6
During the past 7 years, the highest 3-Year average EBIT per Share Growth Rate of Telescope Innovations was 40.60% per year. The lowest was -67.10% per year. And the median was 39.10% per year.
TELIF's 3-Year EBIT Growth Rate is ranked better than 80.05% of 1173
companies
in the Biotechnology industry
Industry Median: 15.4
vs TELIF: 40.60
Telescope Innovations (OTCPK:TELIF) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Telescope Innovations EBIT per Share Related Terms
Telescope Innovations EBIT per Share Historical Data
* Premium members only.
The historical data trend for Telescope Innovations's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in May. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.04
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Telescope Innovations (TELIF) has a EBIT per Share of $-0.04 as of May. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Telescope Innovations and its competitors. According to the industry distribution chart, Telescope Innovations ranks #234 out of 1173 companies in the Biotechnology industry, placing it in the top 19.9%.
Is Telescope Innovations' EBIT per Share too high?
Telescope Innovations' current EBIT per Share is $-0.04. Based on the distribution chart, Telescope Innovations ranks #234 out of 1173 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Telescope Innovations has a GF Score™ of 27/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Telescope Innovations' EBIT per Share compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Telescope Innovations ranks #234 out of 1173 companies for EBIT per Share. This places Telescope Innovations in the top 20% of its industry — outperforming the majority of peers. The industry median EBIT per Share is 15.40. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Biotechnology company?
The median EBIT per Share among Biotechnology companies is 15.40, based on 1,173 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Telescope Innovations and its competitors. For the Biotechnology industry, the median EBIT per Share is 15.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Telescope Innovations's current EBIT per Share is $-0.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Telescope Innovations stock overvalued right now?
Based on GuruFocus' analysis, Telescope Innovations (TELIF) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.38, compared to a current price of $0.53 — trading 38.2% above its estimated fair value. The current EBIT per Share is $-0.04. Telescope Innovations' overall GF Score™ is 27/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Telescope Innovations (TELIF), the current EBIT per Share is $-0.04 as of May. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Telescope Innovations (TELIF) Overvalued in 2026?
Based on GuruFocus' analysis, Telescope Innovations stock appears to be overvalued.
The current stock price of $0.53 is trading 38.2% above its estimated GF Value™ of $0.38.
GuruFocus considers Telescope Innovations to be Significantly Overvalued.
Key valuation signals for TELIF:
EBIT per Share: $-0.04
GF Value™: $0.38 vs. price of $0.53 (38.2% above fair value)
No single metric tells the full story. See the TELIF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Telescope Innovations Corp is a technology company focused on development as a Contract Research Organization (CRO) to develop intellectual property, provide contract research, and build automation products, and operates as a chemical technology company developing scalable manufacturing processes and tools for the pharmaceutical and chemical industry. Its flagship product is the DirectInject-LC system. The Company operates in a single operating segment and generates revenue from three streams: contract research services, grant income, and the sale of automation products, with the majority of revenue derived from automation product sales from customer contracts. It operates in Canada, the United States, Europe, and Asia, with the majority of revenue coming from the United States.
27GF Score
Get the complete analysis for TELIF
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TELIF has been successfully added to your 
